Blood Cancer United Patient Travel Assistance Program
UnknownUnder review·Mar 20, 2026
- Covers
- transportationfinancial assistance
- Enrollment cycle
- unknown
Eligibility
Patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) treated with Belinostat may qualify for financial and travel support. Applicants are directed to contact a Blood Cancer United Information Specialist to determine specific eligibility for various assistance programs.
Status source
(no page content — URL fetch failed)